Navigation Links
T1D Exchange Announces Appointment of Dana Ball as Chief Executive Officer
Date:12/6/2012

BOSTON, Dec. 6, 2012 /PRNewswire/ -- The T1D Exchange, a not-for-profit organization accelerating the discovery of new approaches to type 1 diabetes research and treatment, announced today that Dana Ball has joined the organization as Chief Executive Officer. In his new role, Mr. Ball will oversee the integration and expansion of the T1D Exchange's multiple components, including the clinical registry, biobank and Glu, an online social network for people with type 1 diabetes.  Mr. Ball previously served as Program Director of the Type 1 Diabetes (T1D) Program at The Leona M. and Harry B. Helmsley Charitable Trust and is one of the cofounders of the T1D Exchange. Prior to joining the Helmsley Charitable Trust in 2008, Mr. Ball was Executive Director of the Iacocca Foundation.

The T1D Exchange was designed to connect the disparate stakeholders in the type 1 diabetes community — individuals with type 1 diabetes, caregivers, clinicians, researchers and industry partners — by combining the critical components of a traditional clinical research with the expanding fields of health information technology and social networking. The T1D Exchange was formally established in 2010 through a grant from the Helmsley Charitable Trust's Type 1 Diabetes Program.

"Dana led the design and development of the Helmsley T1D Program and we believe he is the perfect individual to ensure the Exchange fulfill its goals," said David Panzirer, Trustee of the Helmsley Charitable Trust. "The T1D Exchange was one of many programs Dana initiated that has the potential to change the speed and efficiency of research and development for promising new therapies and devices."

"The T1D Exchange began as an abstract idea that Dana found ways to nurture by bringing the right people and resources together.  It would not be where it is now without him. His leadership will help us fulfill the promise this type 1 diabetes resource offers," said Roy W. Beck, MD, PhD, Executive Director of the Jaeb Center for Health Research and Vice President of the T1D Exchange Board of Directors. "The T1D Exchange Clinic Registry, the first initiative of the T1D Exchange Clinic Network, has collected data on over 26 thousand individuals with type 1 diabetes. We are gaining vital knowledge about how type 1 diabetes is managed among individuals of all ages, knowledge we would not have if it were not for the vision of Dana Ball and the Helmsley T1D Program."

Importantly, Glu (www.myglu.org), a website for individuals with type 1 diabetes and their caregivers recently launched. Glu currently has over 3,500 members who log in on a frequent basis, some daily, answering the question of the day, starting or responding to discussions, or participating in research activities, surveys and developing studies. Glu is truly a community with a purpose; dedicated to supporting its members, facilitating research, and empowering people with type 1 diabetes to participate and influence the future of new therapies and solutions. Glu provides the platform to empower patients, acting as a conduit to the drug, device, and R&D community. According to Mr. Ball, "Managing type 1 diabetes is a 24 hour daily requirement to monitor blood sugars and manage insulin delivery in a fashion that mimics what a healthy pancreas does minute by minute.  Glu is designed to support people touched by type 1 diabetes on a daily basis and empower members by participating in research and development projects to advance better technologies and treatments on the path to a cure." Over 90 percent of Glu members responding to the question "Would you donate blood to Type 1 diabetes research," responded yes, demonstrating the proactive nature of participants.

Individuals with type 1 diabetes are being enrolled into the T1D Exchange Clinic Registry at 69 centers throughout the United States. There are presently more than 26 thousand individuals enrolled.  Participants span a wide range of ages, from infants to adults over 90 years of age, with representation across a broad spectrum of racial and ethnic groups. The registry also includes over 250 participants who have had type 1 diabetes for more than 50 years.  Since June 2011, the T1D Exchange has presented 16 abstracts at 5 different national and international diabetes conferences, including the American Diabetes Association's Scientific Sessions, the International Society for Pediatric and Adolescent Diabetes (ISPAD) and the European Association for the Study of Diabetes (EASD).

About the T1D Exchange
The T1D Exchange is a unique platform for collaborative data collection and sharing that consists of three overlapping components: a clinic-based registry with clinical, biological and other real-life information from individuals with type 1 diabetes, a registry that is coordinated through a network of clinical centers and an interactive online community for individuals living with type 1 diabetes. The T1D Exchange is a not-for-profit initiative founded through a three-year grant from The Leona M. and Harry B. Helmsley Charitable Trust and developed in partnership with the Jaeb Center for Health Research.  More information is available at www.t1dexchange.org.


'/>"/>
SOURCE T1D Exchange
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Amarantus BioSciences Demands Cessation of Unauthorized Listing on Berlin-Bremen Stock Exchange
2. BioPower Operations Corporation Announces that FTZ Exchange Signs Strategic Alliance with Capacity 360, LLC and Tom Settineri
3. CSL Behring Awards LEAD Grant to Patient Organizations to Educate Constituents on State Insurance Exchanges
4. Saladax Biomedical, Inc. Announces the Formation of a CLIA Laboratory As Part of the Companys Commercialization Strategy
5. CoreLab Partners, Medical Image Assessment Experts, Announces Its Entry Into the Early Alzheimers Imaging Market Space
6. WISE Surgical Solutions LLC Announces Project Hope: Helping People with Debilitating Conditions Including Arthritis, Parkinson's, MS and Spinal Injury Know Their Options
7. Array BioPharma Announces Exercise And Closing Of Underwriters Over-Allotment Option
8. Gallus BioPharmaceuticals Announces Appointment of Senior Baxter Executive as Chief Commercial Officer
9. Topokine Announces Dosing of First Subject in a Phase I Clinical Trial of XAF5 Gel for Local Reduction of Subcutaneous Fat
10. Biocartis Announces Commercial Launch of a New Biomarker Analysis Platform
11. Chemical Publishing Company Announces its Niche Catalog in the Water Technology and Water Treatment Space
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... 26, 2017  Nurse practitioners play a crucial role in ... a Merck Manuals survey released today. The survey ... that most (88 percent) believe they spend at least half ... ... Merck Manuals survey of 210 nurse practitioners finds that ...
(Date:7/24/2017)... , July 24, 2017 Intralytix, Inc. announced ... from Lesaffre, a French family group. This investment marks ... to develop and commercialize bacteriophage-based products, for various benefits ... interest. As ... designs manufactures and markets innovative solutions for baking, food ...
(Date:7/20/2017)... ... July 20, 2017 , ... Dr. Asher Kimchi, Founder and ... of the 2017 IAC Awards at the 22nd World Congress on Heart Disease held ... four faculty to receive the Distinguished Fellowship Awards. , Dr. Asher Kimchi, together with ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... Corporate Directors ... at its 27th annual Director of the Year Awards. , The awards will be ... Jolla. This annual event celebrates directors who have made significantly positive contributions in ...
Breaking Biology Technology:
(Date:6/14/2017)... June 15, 2017  IBM (NYSE: IBM ) is introducing ... event dedicated to developing collaboration between startups and global businesses, ... 15-17. During the event, nine startups will showcase the solutions ... various industries. France ... market, with a 30 percent increase in the number of ...
(Date:5/16/2017)... DALLAS , May 16, 2017   ... for health organizations, and MD EMR Systems ... certified development partner for GE, have established a ... Patient Portal product and the GE Centricity™ products, ... Centricity EMR. These new integrations ...
(Date:4/19/2017)... 19, 2017 The global military ... is marked by the presence of several large global ... by five major players - 3M Cogent, NEC Corporation, ... for nearly 61% of the global military biometric market ... the global military biometrics market boast global presence, which ...
Breaking Biology News(10 mins):